|
78 |
자궁경부암 |
Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort
|
2024-09-24 |
29 |
|
77 |
자궁경부암 |
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning
|
2024-09-24 |
6 |
|
76 |
자궁경부암 |
Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study
|
2024-09-24 |
0 |
|
75 |
자궁경부암 |
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 tria
|
2024-09-24 |
2 |
|
74 |
자궁체부암 |
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan
|
2024-09-24 |
7 |
|
73 |
자궁체부암 |
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study
|
2024-09-24 |
10 |
|
72 |
자궁체부암 |
Choosing the right adjuvant therapy for stage III–IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy
|
2024-09-24 |
1 |
|
71 |
자궁체부암 |
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis
|
2024-09-24 |
3 |
|
70 |
난소암 |
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).
|
2024-09-24 |
5 |
|
69 |
난소암 |
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
|
2024-09-24 |
3 |
